SCHEMBL6871505

SCHEMBL6871505

CCCCCCC[C@@H](C)OC(=O)c1ccc(-c2ccc(OC(C)=O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
RARB P10826 4/20 0.45
MGLL Q99685 1/20 0.44
FAAH O00519 2/20 0.43
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
PTGS2 P35354 1/20 0.41
PNLIP P16233 1/20 0.41
PDCD1 Q15116 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
KDM4E B2RXH2 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9296056 1.00 ALDH1A1 (0.50) ALDH1A1TSHRHSD17B10RARBMGLL
SCHEMBL9156662 0.96 ALDH1A1 (0.53) ALDH1A1TSHRMGLLFAAHNPC1
SCHEMBL6865273 0.96 ALDH1A1 (0.53) ALDH1A1TSHRMGLLFAAHNPC1
SCHEMBL7799666 0.96 ALDH1A1 (0.53) ALDH1A1TSHRMGLLFAAHNPC1
SCHEMBL6872611 0.92 ALDH1A1 (0.52) ALDH1A1TSHRRARBMGLLNPC1
SCHEMBL6872017 0.92 ALDH1A1 (0.52) ALDH1A1TSHRRARBMGLLNPC1
SCHEMBL6872703 0.91 TSHR (0.51) ALDH1A1TSHRRARBMGLLNPC1
SCHEMBL8610838 0.91 TSHR (0.53) ALDH1A1TSHRHSD17B10MGLLNPC1
SCHEMBL10422540 0.90 HSD17B10 (0.53) TSHRHSD17B10NPC1LMNASMN1; SMN2
SCHEMBL7131644 0.89 ALDH1A1 (0.59) ALDH1A1TSHRRARBFAAHNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821581-B2 ESTER DERIVATIVES OF TEREPHTHALIC ACID ESTERS; HAVE A HELICAL TWISTING POWER OF AT LEAST 9; HELICAL PITCH INDUCED DECREASES IN LENGTH WITH AN INCREASE IN TEMPERATURE. MITSUBISHI GAS CHEMICAL CO., INC. (JP) 2004-11-23 US disclosed
US-20030124268-A1 Optically active compound and liquid crystal composition containing the compound MITSUBISHI GAS CHEMICAL CO., INC. 2003-07-03 US disclosed
EP-1270542-A1 Optically active compound and liquid crystal composition containing the compound MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124268-A1 Optically active compound and liquid crystal composition containing the compound CRY1, CRY2, PNP ALDH1A1 4498/4885TSHR 4000/4885HSD17B10 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.